Results
|
|
3981.
|
|
|
|
3982.
|
[Molecular genetics of pigmentary retinopathies: identification of mutations in CHM, RDS, RHO, RPE65, USH2A and XLRS1 genes]. [electronic resource] by
- Hamel, C P
- Griffoin, J M
- Bazalgette, C
- Lasquellec, L
- Duval, P A
- Bareil, C
- Beaufrère, L
- Bonnet, S
- Eliaou, C
- Marlhens, F
- Schmitt-Bernard, C F
- Tuffery, S
- Claustres, M
- Arnaud, B
Producer: 20010222
In:
Journal francais d'ophtalmologie vol. 23
Availability: No items available.
|
|
|
3983.
|
|
|
|
3984.
|
A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer. [electronic resource] by
- Lebowitz, Peter F
- Eng-Wong, Jennifer
- Widemann, Brigitte C
- Balis, Frank M
- Jayaprakash, Nalini
- Chow, Catherine
- Clark, Geoff
- Gantz, Susan B
- Venzon, David
- Zujewski, JoAnne
Producer: 20050531
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11
Availability: No items available.
|
|
|
3985.
|
Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome. [electronic resource] by
- Kurzrock, Razelle
- Albitar, Maher
- Cortes, Jorge E
- Estey, Elihu H
- Faderl, Stefan H
- Garcia-Manero, Guillermo
- Thomas, Deborah A
- Giles, Francis J
- Ryback, Mary Ellen
- Thibault, Alain
- De Porre, P
- Kantarjian, Hagop M
Producer: 20040420
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 22
Availability: No items available.
|
|
|
3986.
|
|
|
|
3987.
|
|
|
|
3988.
|
|
|
|
3989.
|
Dammarenediol-II Prevents VEGF-Mediated Microvascular Permeability in Diabetic Mice. [electronic resource] by
- Kim, Su-Hyeon
- Jung, Se-Hui
- Lee, Yeon-Ju
- Han, Jung Yeon
- Choi, Yong-Eui
- Hong, Hae-Deun
- Jeon, Hye-Yoon
- Hwang, JongYun
- Na, SungHun
- Kim, Young-Myeong
- Ha, Kwon-Soo
Producer: 20160610
In:
Phytotherapy research : PTR vol. 29
Availability: No items available.
|
|
|
3990.
|
|
|
|
3991.
|
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency. [electronic resource] by
- Bell, I M
- Gallicchio, S N
- Abrams, M
- Beshore, D C
- Buser, C A
- Culberson, J C
- Davide, J
- Ellis-Hutchings, M
- Fernandes, C
- Gibbs, J B
- Graham, S L
- Hartman, G D
- Heimbrook, D C
- Homnick, C F
- Huff, J R
- Kassahun, K
- Koblan, K S
- Kohl, N E
- Lobell, R B
- Lynch, J J
- Miller, P A
- Omer, C A
- Rodrigues, A D
- Walsh, E S
- Williams, T M
Producer: 20010927
In:
Journal of medicinal chemistry vol. 44
Availability: No items available.
|
|
|
3992.
|
|
|
|
3993.
|
|
|
|
3994.
|
|
|
|
3995.
|
|
|
|
3996.
|
|
|
|
3997.
|
|
|
|
3998.
|
|
|
|
3999.
|
|
|
|
4000.
|
|